⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPRX News
Kiora Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
SSII
RBOT
KPRX
Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
Form 8-K
sec.gov
KPHMW
KPRX
ICIC Celebrates National Small Business Changemakers and 2025 IC100 Award Winners
globenewswire.com
KPRX
BAC
FDX
HD
INTU
RF
GS
Form 8-K
sec.gov
KPHMW
KPRX
Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway Ready to Announce with Confidence?
newsfilecorp.com
KPRX
Form 8-K
sec.gov
PSTV
KPRX